Pro PG receives S19A approval for OXYBUTYNIN CHLORIDE 5mg [100] Tabs (Novitium Pharma LLC, USA)

Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered DITROPAN oxybutynin hydrochloride 5mg tablet bottle AUST R: 48965. ProPG has arranged for an alternative product Oxybutynin Chloride Tablets, USP 5mg (Novitium Pharma, USA) . The S19A product is registered and marketed in the USA and the supply is authorized under an exemption granted by the TGA under Section 19A of the Therapeutic Goods Act, 1989 until 31 January 2023.